EUVIMEDEUVIMED entdecken
Crossref

“Three‐in‐One” Nanozyme Composite for Augmented Cascade Catalytic Tumor Therapy

Yue Cheng iD, Yue-Dang Xia, Yi-Qing Sun, Yong Wang, Xue-Bo Yin iD

Advanced Materials · 2024-02 · 36 (8)

DOI: 10.1002/adma.202308033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 14.12.2023. Verfasst von Yue Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Science, Tianjin University, Tianjin, 300072, China. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Neoplasms. Die Arbeit wurde bisher 163-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cascade catalytic reaction exhibits simple procedure and high efficiency, such as that from the orderly assembly of different enzymes in biological systems. Mimicking of the natural cascade procedure becomes critical, but the orderly assembly of different enzymes is still challenging. Herein, single Au–Pt nanozyme is reported with “three‐in‐one” functions to initiate cascade conversions for O 2 supply as mimic catalase, H 2 O 2 production with its glucose oxidase‐like property, and • OH generation as mimic peroxidase for chemodynamic therapy (CDT). Thus, the complex assembly and cross‐talk among the different enzymes are avoided. To this end, metastable Cu 2 O NPs, as scaffolds, are used to anchor ultrasmall Au–Pt nanozyme, while metal–organic framework (MOF) is used to encapsulate the nanozyme for tumor microenvironment response and shielding protein adsorption. Pluronic F127 is then modified on the surface to improve hydrophilicity and biocompatibility of the composite. The endogenous acidity and glutathione in tumor degrade MOF to expose nanozyme for cascade catalytic CDT. The high photothermal conversion ability also enhances the CDT, while Cu 2+ ions consume GSH to further improve CDT efficiency as augmented cascade catalytic tumor therapy. Thus, a new paradigm is provided with drug‐free single nanozyme for improving tumor therapeutic efficacy and minimizing side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal-Organic FrameworksNeoplasmsHumansPeroxidasePeroxidasesAdsorptionCatalysisColoring AgentsGlutathioneTumor MicroenvironmentCell Line, TumorHydrogen Peroxide

Stichwörter der Autor:innen

Au-Pt nanozymecascade catalytic reactionsdrug-free tumor therapymetal-organic framework

Substanzen

PeroxidasePeroxidasesColoring AgentsGlutathioneMetal-Organic FrameworksHydrogen Peroxide

Autor:innen und Institutionen

  • Department of Chemistry, School of Science, Tianjin University, Tianjin, 300072, China.
  • Research Center for Analytical Science, College of Chemistry, Nankai University, Tianjin, 300071, China.
  • Laboratory Equipment Department, Nankai University, Tianjin, 300071, China.
  • Institute of Frontier Medical Technology, College of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai, 201620, China.

ORCID-Profile: Yue Cheng, Xue-Bo Yin

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Cheng, Y., Xia, Y. D., Sun, Y. Q., Wang, Y., & Yin, X. B. (2024). “Three‐in‐One” Nanozyme Composite for Augmented Cascade Catalytic Tumor Therapy. Advanced Materials, 36(8). https://doi.org/10.1002/adma.202308033

Vancouver

Cheng Y, Xia YD, Sun YQ, Wang Y, Yin XB. “Three‐in‐One” Nanozyme Composite for Augmented Cascade Catalytic Tumor Therapy. Advanced Materials. 2024;36(8). doi:10.1002/adma.202308033

BibTeX
@article{Cheng2024,
  author = {Cheng, Yue and Xia, Yue-Dang and Sun, Yi-Qing and Wang, Yong and Yin, Xue-Bo},
  title = {“Three‐in‐One” Nanozyme Composite for Augmented Cascade Catalytic Tumor Therapy},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {8},
  doi = {10.1002/adma.202308033}
}
Kostenlos starten →